Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
J Immunol ; 199(3): 911-919, 2017 08 01.
Artigo em Inglês | MEDLINE | ID: mdl-28652395

RESUMO

In response to acute viral infection, activated naive T cells give rise to effector T cells that clear the pathogen and memory T cells that persist long-term and provide heightened protection. T cell factor 1 (Tcf1) is essential for several of these differentiation processes. Tcf1 is expressed in multiple isoforms, with all isoforms sharing the same HDAC and DNA-binding domains and the long isoforms containing a unique N-terminal ß-catenin-interacting domain. In this study, we specifically ablated Tcf1 long isoforms in mice, while retaining expression of Tcf1 short isoforms. During CD8+ T cell responses, Tcf1 long isoforms were dispensable for generating cytotoxic CD8+ effector T cells and maintaining memory CD8+ T cell pool size, but they contributed to optimal maturation of central memory CD8+ T cells and their optimal secondary expansion in a recall response. In contrast, Tcf1 long isoforms were required for differentiation of T follicular helper (TFH) cells, but not TH1 effectors, elicited by viral infection. Although Tcf1 short isoforms adequately supported Bcl6 and ICOS expression in TFH cells, Tcf1 long isoforms remained important for suppressing the expression of Blimp1 and TH1-associated genes and for positively regulating Id3 to restrain germinal center TFH cell differentiation. Furthermore, formation of memory TH1 and memory TFH cells strongly depended on Tcf1 long isoforms. These data reveal that Tcf1 long and short isoforms have distinct, yet complementary, functions and may represent an evolutionarily conserved means to ensure proper programming of CD8+ and CD4+ T cell responses to viral infection.


Assuntos
Linfócitos T CD4-Positivos/imunologia , Linfócitos T CD8-Positivos/imunologia , Coriomeningite Linfocítica/imunologia , Vírus da Coriomeningite Linfocítica/imunologia , Fator 1 de Transcrição de Linfócitos T/química , Fator 1 de Transcrição de Linfócitos T/imunologia , Animais , Diferenciação Celular , Testes Imunológicos de Citotoxicidade , Centro Germinativo/citologia , Centro Germinativo/imunologia , Centro Germinativo/metabolismo , Memória Imunológica , Proteína Coestimuladora de Linfócitos T Induzíveis/genética , Proteína Coestimuladora de Linfócitos T Induzíveis/metabolismo , Proteínas Inibidoras de Diferenciação/genética , Proteínas Inibidoras de Diferenciação/metabolismo , Vírus da Coriomeningite Linfocítica/isolamento & purificação , Camundongos , Fator 1 de Ligação ao Domínio I Regulador Positivo , Isoformas de Proteínas , Proteínas Proto-Oncogênicas c-bcl-6/genética , Proteínas Proto-Oncogênicas c-bcl-6/metabolismo , Fator 1 de Transcrição de Linfócitos T/deficiência , Fator 1 de Transcrição de Linfócitos T/genética , Fatores de Transcrição/genética , Fatores de Transcrição/metabolismo
2.
J Neuropathol Exp Neurol ; 36(1): 9-20, 1977 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-833620

RESUMO

Lymphocytic choriomeningitis virus-induced central nervous system disease is characterized by death during a seizure approximately seven days after intracerebral inoculation. This process is mediated by thymus dependent lymphocytes, sensitized against viral antigens. Various forms of immunosuppressive treatment prevent the seizure death and produce persistently infected survivors. In this study, anticonvulsant treatment (particularly diazepam treatment) of LCM virus infected mice prolonged survival without affecting viral replication, or suppressing immune responsiveness. This prolongation of life did not lead to a reversal of pathologic processes and there were no survivors. However, anticonvulsant treatment permitted study of more advanced stages of the choriomeningitis than has previously been possible.


Assuntos
Anticonvulsivantes/uso terapêutico , Coriomeningite Linfocítica/tratamento farmacológico , Animais , Diazepam/administração & dosagem , Diazepam/uso terapêutico , Avaliação Pré-Clínica de Medicamentos , Coriomeningite Linfocítica/imunologia , Coriomeningite Linfocítica/mortalidade , Vírus da Coriomeningite Linfocítica/isolamento & purificação , Camundongos , Fenobarbital/uso terapêutico , Fenitoína/uso terapêutico
3.
J Virol ; 15(6): 1317-22, 1975 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-1170337

RESUMO

Two procedures for the purification of infectious lymphocytic choriomeningitis virus from cell culture fluid have been developed. If large quantities of very pure virus are to be prepared, infected L cells are maintained with a medium supplemented with calf serum, the proteins of which have been largely removed by pretreatment with polyethylene glycol. Two days after infection of the cultures, the media are collected and the virus is concentrated by treatment with polyethylene glycol 40,000. Purification with a 10,000-fold increase of specific infectivity is achieved with steric chromatography on controlled-pore glass beads with pore sizes of 42 to 44 nm and centrifugation in density gradients prepared with amido trizoate. An alternative method begins with precipitation of the virus from infected cell cuture medium with zinc acetate, followed by controlled-pore glass chromatography and density centrifugation in a discontinuous sucrose gradient. Purification thus obtained is 200-fold in terms of specific infectivity.


Assuntos
Vírus da Coriomeningite Linfocítica/isolamento & purificação , Acetatos , Animais , Divisão Celular , Centrifugação com Gradiente de Concentração , Precipitação Química , Cromatografia , Meios de Cultura , Diatrizoato , Vidro , Células L , Camundongos , Polietilenoglicóis , Sacarose
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA